Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition By Mary • January 30, 2023January 30, 2023 Check out our recent publication on PubMed about our pilot study exploring Ketamine for treatment-resistant depression (TRD)! Related